Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Cryoport, LabConnect announce partnership » 08:47
05/06/21
05/06
08:47
05/06/21
08:47
CYRX

Cryoport

$61.53 /

+6.79 (+12.40%)

LabConnect and Cryoport…

LabConnect and Cryoport announced a partnership to provide comprehensive logistics support for an upcoming Phase I/II clinical trial sponsored by Triumvira Immunologics, a privately held biopharmaceutical company developing a novel platform for engineering T cells to attack cancers. The study intends to investigate the safety and efficacy of autologous TAC-T Cells targeting HER2 in relapsed or refractory solid tumors. The partnership will integrate Cryoport's Cryoportal Logistics Management Platform and LabConnect's SampleGISTICS platform to provide Triumvira with the highest possible available level of tracking and proactive management for their samples, source materials, and therapeutic product. Each step from scheduling, sample collection, confirming courier pickups/deliveries, and monitoring transport will be monitored by LabConnect and Cryoport project management.

ShowHide Related Items >><<
CYRX Cryoport
$61.53 /

+6.79 (+12.40%)

CYRX Cryoport
$61.53 /

+6.79 (+12.40%)

03/15/21
Fly Intel: Top five analyst initiations
03/15/21 UBS
Cryoport initiated with a Buy at UBS
03/02/21
Fly Intel: Top five analyst initiations
03/02/21 Needham
Cryoport assumed with a Buy at Needham
CYRX Cryoport
$61.53 /

+6.79 (+12.40%)

  • 21
    Jan
CYRX Cryoport
$61.53 /

+6.79 (+12.40%)

Earnings
Cryoport reports Q1 EPS (13c), consensus (18c) » 16:48
05/04/21
05/04
16:48
05/04/21
16:48
CYRX

Cryoport

$54.99 /

-1.43 (-2.53%)

Reports Q1 revenue…

Reports Q1 revenue $53.3M, consensus $46.78M. Jerrell Shelton, CEO, said, "It was a strong quarter and it developed as we had anticipated. We entered 2021 with an unrivaled leadership position with market-leading temperature-controlled supply chain solutions for the life sciences industry in our markets of Biopharma/Pharma, Animal Health and Reproductive Medicine. Our global platform, consisting of 32 locations and a family of companies that provide mutually reinforcing solutions, services and products, delivered an outstanding performance. Cryoport's revenue grew to a record $53.3M for the quarter with our recent acquisitions of MVE Biological Solutions and CRYOPDP contributing significantly as we navigated the ongoing integration of these two fine acquisitions. I would like to emphasize that all our business units reported record revenue as well as strong sequential growth over our record Q4 2020. This performance was primarily driven by the Biopharma/Pharma market, which represented approximately 80% of our total revenue in the Q1 of 2021. It is notable that we continued to build out our pipeline of potential commercial customers with the total number of regenerative medicine clinical trials supported by Cryoport reaching a record 543 trials compared with 465 at the end of the Q1 of 2020 as well as adding 2 new commercial launches supported by Cryoport.

ShowHide Related Items >><<
CYRX Cryoport
$54.99 /

-1.43 (-2.53%)

CYRX Cryoport
$54.99 /

-1.43 (-2.53%)

03/15/21
Fly Intel: Top five analyst initiations
03/15/21 UBS
Cryoport initiated with a Buy at UBS
03/02/21
Fly Intel: Top five analyst initiations
03/02/21 Needham
Cryoport assumed with a Buy at Needham
CYRX Cryoport
$54.99 /

-1.43 (-2.53%)

  • 21
    Jan
CYRX Cryoport
$54.99 /

-1.43 (-2.53%)

Over a month ago
Conference/Events
Alliance for Regenerative Medicine to hold a virtual meeting » 04:55
04/09/21
04/09
04:55
04/09/21
04:55
BLUE

Bluebird Bio

$28.86 /

-1.2 (-3.99%)

, GILD

Gilead

$65.03 /

-0.56 (-0.85%)

, TMO

Thermo Fisher

$471.57 /

+5.26 (+1.13%)

, SGTX

Sigilon Therapeutics

$17.81 /

-0.5 (-2.73%)

, ADAP

Adaptimmune

$5.12 /

+0.16 (+3.23%)

, AGTC

Applied Genetic

$4.57 /

+0.115 (+2.58%)

, ATRA

Atara Biotherapeutics

$14.18 /

-0.035 (-0.25%)

, CABA

Cabaletta Bio

$10.77 /

+0.155 (+1.46%)

, FLXN

Flexion

$8.30 /

-0.03 (-0.36%)

, DTIL

Precision BioSciences

$8.94 /

+0.025 (+0.28%)

, DOV

Dover

$138.50 /

-0.465 (-0.33%)

, GNPX

Genprex

$4.88 /

+0.805 (+19.78%)

, DBTX

Decibel Therapeutics

$10.71 /

-0.35 (-3.16%)

, CYRX

Cryoport

$53.88 /

+2.68 (+5.23%)

, GLW

Corning

$44.57 /

+0.27 (+0.61%)

, FTV

Fortive

$70.23 /

-1.16 (-1.62%)

, KRYS

Krystal Biotech

$73.50 /

-0.25 (-0.34%)

, NVO

Novo Nordisk

$69.24 /

+1.375 (+2.03%)

, NVS

Novartis

$87.02 /

+0.705 (+0.82%)

, ORTX

Orchard Therapeutics

$6.96 /

+0.09 (+1.31%)

, MRK

Merck

$75.48 /

-0.65 (-0.85%)

, MEDP

Medpace

$169.50 /

+1.6 (+0.95%)

, IOVA

Iovance Biotherapeutics

$31.30 /

+0.31 (+1.00%)

, FOLD

Amicus

$9.27 /

-0.0999 (-1.07%)

Cell & Gene Virtual…

Cell & Gene Virtual Meeting on the Mediterranean will be held on April 6-9. Webcast Link

ShowHide Related Items >><<
TMO Thermo Fisher
$471.57 /

+5.26 (+1.13%)

SGTX Sigilon Therapeutics
$17.81 /

-0.5 (-2.73%)

ORTX Orchard Therapeutics
$6.96 /

+0.09 (+1.31%)

NVS Novartis
$87.02 /

+0.705 (+0.82%)

NVO Novo Nordisk
$69.24 /

+1.375 (+2.03%)

MRK Merck
$75.48 /

-0.65 (-0.85%)

KRYS Krystal Biotech
$73.50 /

-0.25 (-0.34%)

IOVA Iovance Biotherapeutics
$31.30 /

+0.31 (+1.00%)

GNPX Genprex
$4.88 /

+0.805 (+19.78%)

GLW Corning
$44.57 /

+0.27 (+0.61%)

GILD Gilead
$65.03 /

-0.56 (-0.85%)

FTV Fortive
$70.23 /

-1.16 (-1.62%)

FOLD Amicus
$9.27 /

-0.0999 (-1.07%)

FLXN Flexion
$8.30 /

-0.03 (-0.36%)

DTIL Precision BioSciences
$8.94 /

+0.025 (+0.28%)

DOV Dover
$138.50 /

-0.465 (-0.33%)

DBTX Decibel Therapeutics
$10.71 /

-0.35 (-3.16%)

CYRX Cryoport
$53.88 /

+2.68 (+5.23%)

CABA Cabaletta Bio
$10.77 /

+0.155 (+1.46%)

BLUE Bluebird Bio
$28.86 /

-1.2 (-3.99%)

ATRA Atara Biotherapeutics
$14.18 /

-0.035 (-0.25%)

AGTC Applied Genetic
$4.57 /

+0.115 (+2.58%)

ADAP Adaptimmune
$5.12 /

+0.16 (+3.23%)

BLUE Bluebird Bio
$28.86 /

-1.2 (-3.99%)

03/29/21 BMO Capital
Bluebird Bio price target raised to $35 from $31 at BMO Capital
03/29/21 Mizuho
Bluebird Bio approval could improve sentiment on shares, says Mizuho
03/29/21 Piper Sandler
Bluebird Bio price target raised to $35 from $30 at Piper Sandler
03/17/21 Stifel
Stifel says Bluebird Bio CMO exit 'a bit concerning but not thesis changing'
GILD Gilead
$65.03 /

-0.56 (-0.85%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Bernstein
Gilead upgraded to Outperform from Market Perform at Bernstein
03/30/21 Redburn
Gilead upgraded to Buy from Neutral at Redburn
03/15/21 Mizuho
Merck's Gilead collaboration likely to broaden reach of islatravir, says Mizuho
TMO Thermo Fisher
$471.57 /

+5.26 (+1.13%)

03/29/21 UBS
Thermo Fisher price target lowered to $560 from $588 at UBS
03/18/21 KeyBanc
Thermo Fisher upgraded to Overweight at KeyBanc after Sartorius guidance
03/18/21 KeyBanc
Thermo Fisher upgraded to Overweight from Sector Weight at KeyBanc
03/02/21 Barclays
Thermo Fisher initiated with an Overweight at Barclays
SGTX Sigilon Therapeutics
$17.81 /

-0.5 (-2.73%)

12/29/20 Barclays
Sigilon Therapeutics initiated with an Overweight at Barclays
12/29/20 Morgan Stanley
Sigilon Therapeutics initiated with an Equal Weight at Morgan Stanley
12/29/20 Jefferies
Sigilon Therapeutics initiated with a Buy at Jefferies
ADAP Adaptimmune
$5.12 /

+0.16 (+3.23%)

08/12/20 Piper Sandler
TCR2 Therapeutics initiated with an Overweight at Piper Sandler
06/01/20 Mizuho
Adaptimmune price target raised to $9 from $3 at Mizuho
05/29/20 JonesTrading
JonesTrading upgrades Adaptimmune to Buy after data alleviates 'key concern'
05/29/20 JonesTrading
Adaptimmune upgraded to Buy from Hold at JonesTrading
AGTC Applied Genetic
$4.57 /

+0.115 (+2.58%)

03/01/21 Stifel
Applied Genetic initiated with a Buy at Stifel
02/02/21 H.C. Wainwright
Applied Genetic price target raised to $24 from $18 at H.C. Wainwright
02/01/21 Roth Capital
Applied Genetic price target raised to $35 from $30 at Roth Capital
11/17/20 Roth Capital
Applied Genetic price target raised to $30 from $26 at Roth Capital
ATRA Atara Biotherapeutics
$14.18 /

-0.035 (-0.25%)

03/25/21 Evercore ISI
Viracta Therapeutics initiated with an Outperform at Evercore ISI
03/02/21 Citi
Atara Biotherapeutics upgraded to Buy at Citi following 35% pullback
03/02/21 Citi
Atara Biotherapeutics upgraded to Buy from Neutral at Citi
01/04/21 Roth Capital
Roth keeps Buy rating on Atara Biotherapeutics after filing delay
CABA Cabaletta Bio
$10.77 /

+0.155 (+1.46%)

03/17/21 H.C. Wainwright
Cabaletta Bio price target raised to $22 from $20 at H.C. Wainwright
01/08/21 Chardan
Cabaletta Bio initiated with a Buy at Chardan
10/13/20 H.C. Wainwright
Cabaletta Bio initiated with a Buy at H.C. Wainwright
FLXN Flexion
$8.30 /

-0.03 (-0.36%)

04/06/21 RBC Capital
Flexion transferred with an Outperform at RBC Capital
08/20/20 Goldman Sachs
Flexion initiated with a Neutral at Goldman Sachs
07/30/20 Oppenheimer
Flexion initiated with an Outperform at Oppenheimer
07/29/20
Fly Intel: Top five analyst initiations
DTIL Precision BioSciences
$8.94 /

+0.025 (+0.28%)

04/06/21 Stifel
Stifel sees Precision BioSciences' CEO transition as 'disconcerting'
02/24/21
Fly Intel: Top five analyst initiations
02/24/21 JonesTrading
Precision BioSciences initiated with a Buy at JonesTrading
01/29/21 JPMorgan
Precision BioSciences price target raised to $14 from $10 at JPMorgan
DOV Dover
$138.50 /

-0.465 (-0.33%)

04/06/21 Barclays
Dover price target raised to $155 from $145 at Barclays
01/28/21 Baird
Dover price target raised to $147 from $140 at Baird
01/28/21 Baird
Dover results a solid beat with guidance above consensus, says Baird
01/05/21 Barclays
Dover price target raised to $141 from $138 at Barclays
GNPX Genprex
$4.88 /

+0.805 (+19.78%)

01/26/21 National Securities
Genprex initiated with a Buy at National Securities
04/22/20 Alliance Global Partners
Genprex initiated with a Buy at Alliance Global Partners
DBTX Decibel Therapeutics
$10.71 /

-0.35 (-3.16%)

03/09/21 Citi
Decibel Therapeutics initiated with a Buy at Citi
03/09/21 SVB Leerink
Decibel Therapeutics initiated with an Outperform at SVB Leerink
03/09/21 Barclays
Decibel Therapeutics initiated with an Overweight at Barclays
03/09/21 BMO Capital
Decibel Therapeutics initiated with an Outperform at BMO Capital
CYRX Cryoport
$53.88 /

+2.68 (+5.23%)

03/15/21
Fly Intel: Top five analyst initiations
03/15/21 UBS
Cryoport initiated with a Buy at UBS
03/02/21
Fly Intel: Top five analyst initiations
03/02/21 Needham
Cryoport assumed with a Buy at Needham
GLW Corning
$44.57 /

+0.27 (+0.61%)

04/07/21 Argus
Corning price target raised to $54 from $42 at Argus
01/28/21 Oppenheimer
Corning upgraded to Outperform from Perform at Oppenheimer
01/14/21 Barclays
Corning upgraded to Overweight with $44 target at Barclays
01/14/21 Barclays
Corning upgraded to Overweight from Equal Weight at Barclays
FTV Fortive
$70.23 /

-1.16 (-1.62%)

04/06/21 Barclays
Fortive price target raised to $73 from $72 at Barclays
02/17/21
Fly Intel: Top five analyst downgrades
02/17/21 Morgan Stanley
Fortive downgraded to Equal Weight at Morgan Stanley after re-rating
02/17/21 Morgan Stanley
Fortive downgraded to Equal Weight from Overweight at Morgan Stanley
KRYS Krystal Biotech
$73.50 /

-0.25 (-0.34%)

03/01/21 H.C. Wainwright
Krystal Biotech price target raised to $103 from $84 at H.C. Wainwright
03/01/21 William Blair
Krystal Biotech has 'catalyst-rich year ahead,' says William Blair
02/09/21 JonesTrading
Krystal Biotech initiated with a Buy at JonesTrading
01/15/21 Chardan
Krystal Biotech named a 'Top Pick for 2021' at Chardan
NVO Novo Nordisk
$69.24 /

+1.375 (+2.03%)

02/11/21 UBS
Novo Nordisk price target raised to DKK 425 from DKK 415 at UBS
02/04/21 Barclays
Novo Nordisk price target raised to DKK 495 from DKK 485 at Barclays
01/20/21 Citi
Citi opens 'Positive Catalyst Watch' on Novo Nordisk
01/20/21 Credit Suisse
Novo Nordisk downgraded to Neutral from Outperform at Credit Suisse
NVS Novartis
$87.02 /

+0.705 (+0.82%)

04/05/21 Morgan Stanley
Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley
03/23/21 Societe Generale
Novartis price target raised to CHF 107 from CHF 104 at Societe Generale
03/22/21 Bernstein
Novartis initiated with a Market Perform at Bernstein
03/10/21
Fly Intel: Top five analyst downgrades
ORTX Orchard Therapeutics
$6.96 /

+0.09 (+1.31%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
MRK Merck
$75.48 /

-0.65 (-0.85%)

04/08/21 Alliance Global Partners
Alliance Global Partners sees Fast Track for Immutep efti as meaningful positive
04/08/21 H.C. Wainwright
Alkermes collaboration not as big as investors wanted, says H.C. Wainwright
04/07/21 Mizuho
Mizuho sees Alkermes, Merck collaboration as important next step for nemvaleukin
04/06/21 RBC Capital
Merck transferred with a Sector Perform at RBC Capital
MEDP Medpace
$169.50 /

+1.6 (+0.95%)

02/17/21 Truist
Medpace price target raised to $180 from $135 at Truist
02/16/21 Credit Suisse
Medpace price target raised to $178 from $155 at Credit Suisse
10/02/20 Truist
Medpace upgraded to Buy from Hold at Truist
07/29/20 Truist
Medpace price target raised to $124 from $95 at SunTrust
IOVA Iovance Biotherapeutics
$31.30 /

+0.31 (+1.00%)

03/08/21 H.C. Wainwright
Iovance Biotherapeutics upgraded to Buy from Neutral at H.C. Wainwright
01/29/21 Baird
Iovance Biotherapeutics assumed at Outperform at Baird
01/14/21 Oppenheimer
Iovance Biotherapeutics price target raised to $57 from $43 at Oppenheimer
12/17/20 Barclays
Iovance Biotherapeutics price target raised to $55 from $43 at Barclays
FOLD Amicus
$9.27 /

-0.0999 (-1.07%)

03/01/21 Stifel
Amicus initiated with a Hold at Stifel
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 JPMorgan
Amicus downgraded to Neutral on Pompe disease miss at JPMorgan
02/12/21 SVB Leerink
Amicus downgraded to Market Perform from Outperform at SVB Leerink
TMO Thermo Fisher
$471.57 /

+5.26 (+1.13%)

SGTX Sigilon Therapeutics
$17.81 /

-0.5 (-2.73%)

ORTX Orchard Therapeutics
$6.96 /

+0.09 (+1.31%)

NVS Novartis
$87.02 /

+0.705 (+0.82%)

NVO Novo Nordisk
$69.24 /

+1.375 (+2.03%)

MRK Merck
$75.48 /

-0.65 (-0.85%)

MEDP Medpace
$169.50 /

+1.6 (+0.95%)

KRYS Krystal Biotech
$73.50 /

-0.25 (-0.34%)

IOVA Iovance Biotherapeutics
$31.30 /

+0.31 (+1.00%)

GLW Corning
$44.57 /

+0.27 (+0.61%)

GILD Gilead
$65.03 /

-0.56 (-0.85%)

FTV Fortive
$70.23 /

-1.16 (-1.62%)

FOLD Amicus
$9.27 /

-0.0999 (-1.07%)

FLXN Flexion
$8.30 /

-0.03 (-0.36%)

DTIL Precision BioSciences
$8.94 /

+0.025 (+0.28%)

DOV Dover
$138.50 /

-0.465 (-0.33%)

CYRX Cryoport
$53.88 /

+2.68 (+5.23%)

CABA Cabaletta Bio
$10.77 /

+0.155 (+1.46%)

BLUE Bluebird Bio
$28.86 /

-1.2 (-3.99%)

ATRA Atara Biotherapeutics
$14.18 /

-0.035 (-0.25%)

AGTC Applied Genetic
$4.57 /

+0.115 (+2.58%)

ADAP Adaptimmune
$5.12 /

+0.16 (+3.23%)

  • 12
    Feb
  • 03
    Feb
  • 28
    Jan
  • 21
    Jan
  • 09
    Dec
  • 04
    Dec
  • 02
    Jun
  • 29
    May
  • 27
    May
  • 21
    May
  • 19
    May
  • 19
    May
TMO Thermo Fisher
$471.57 /

+5.26 (+1.13%)

NVS Novartis
$87.02 /

+0.705 (+0.82%)

MRK Merck
$75.48 /

-0.65 (-0.85%)

GLW Corning
$44.57 /

+0.27 (+0.61%)

GILD Gilead
$65.03 /

-0.56 (-0.85%)

FTV Fortive
$70.23 /

-1.16 (-1.62%)

FOLD Amicus
$9.27 /

-0.0999 (-1.07%)

CYRX Cryoport
$53.88 /

+2.68 (+5.23%)

BLUE Bluebird Bio
$28.86 /

-1.2 (-3.99%)

TMO Thermo Fisher
$471.57 /

+5.26 (+1.13%)

SGTX Sigilon Therapeutics
$17.81 /

-0.5 (-2.73%)

NVS Novartis
$87.02 /

+0.705 (+0.82%)

MRK Merck
$75.48 /

-0.65 (-0.85%)

GLW Corning
$44.57 /

+0.27 (+0.61%)

GILD Gilead
$65.03 /

-0.56 (-0.85%)

FOLD Amicus
$9.27 /

-0.0999 (-1.07%)

DTIL Precision BioSciences
$8.94 /

+0.025 (+0.28%)

DOV Dover
$138.50 /

-0.465 (-0.33%)

DBTX Decibel Therapeutics
$10.71 /

-0.35 (-3.16%)

BLUE Bluebird Bio
$28.86 /

-1.2 (-3.99%)

ATRA Atara Biotherapeutics
$14.18 /

-0.035 (-0.25%)

AGTC Applied Genetic
$4.57 /

+0.115 (+2.58%)

NVO Novo Nordisk
$69.24 /

+1.375 (+2.03%)

MRK Merck
$75.48 /

-0.65 (-0.85%)

GLW Corning
$44.57 /

+0.27 (+0.61%)

GILD Gilead
$65.03 /

-0.56 (-0.85%)

FOLD Amicus
$9.27 /

-0.0999 (-1.07%)

CABA Cabaletta Bio
$10.77 /

+0.155 (+1.46%)

BLUE Bluebird Bio
$28.86 /

-1.2 (-3.99%)

Conference/Events
Alliance for Regenerative Medicine to hold a virtual meeting » 04:55
04/08/21
04/08
04:55
04/08/21
04:55
BLUE

Bluebird Bio

$30.06 /

-0.1 (-0.33%)

, GILD

Gilead

$65.59 /

-0.67 (-1.01%)

, TMO

Thermo Fisher

$466.27 /

-2.75 (-0.59%)

, SGTX

Sigilon Therapeutics

$18.35 /

-0.64 (-3.37%)

, ADAP

Adaptimmune

$4.96 /

-0.3 (-5.70%)

, AGTC

Applied Genetic

$4.45 /

-0.29 (-6.12%)

, ATRA

Atara Biotherapeutics

$14.22 /

+0.065 (+0.46%)

, CABA

Cabaletta Bio

$10.54 /

-1.02 (-8.82%)

, FLXN

Flexion

$8.34 /

-0.37 (-4.25%)

, DTIL

Precision BioSciences

$8.92 /

-0.34 (-3.67%)

, DOV

Dover

$139.17 /

-0.27 (-0.19%)

, GNPX

Genprex

$4.07 /

-0.23 (-5.35%)

, DBTX

Decibel Therapeutics

$11.06 /

-0.44 (-3.83%)

, CYRX

Cryoport

$51.23 /

-0.27 (-0.52%)

, GLW

Corning

$44.30 /

-0.38 (-0.85%)

, FTV

Fortive

$71.39 /

+0.25 (+0.35%)

, KRYS

Krystal Biotech

$73.72 /

-0.23 (-0.31%)

, NVO

Novo Nordisk

$67.86 /

-0.185 (-0.27%)

, NVS

Novartis

$86.30 /

-0.09 (-0.10%)

, ORTX

Orchard Therapeutics

$6.87 /

-0.22 (-3.10%)

, MRK

Merck

$76.13 /

+0.34 (+0.45%)

, MEDP

Medpace

$167.40 /

-7.13 (-4.09%)

, IOVA

Iovance Biotherapeutics

$31.02 /

-0.98 (-3.06%)

, FOLD

Amicus

$9.37 /

-0.19 (-1.99%)

Cell & Gene Virtual…

Cell & Gene Virtual Meeting on the Mediterranean will be held on April 6-9. Webcast Link

ShowHide Related Items >><<
TMO Thermo Fisher
$466.27 /

-2.75 (-0.59%)

SGTX Sigilon Therapeutics
$18.35 /

-0.64 (-3.37%)

ORTX Orchard Therapeutics
$6.87 /

-0.22 (-3.10%)

NVS Novartis
$86.30 /

-0.09 (-0.10%)

NVO Novo Nordisk
$67.86 /

-0.185 (-0.27%)

MRK Merck
$76.13 /

+0.34 (+0.45%)

KRYS Krystal Biotech
$73.72 /

-0.23 (-0.31%)

IOVA Iovance Biotherapeutics
$31.02 /

-0.98 (-3.06%)

GNPX Genprex
$4.07 /

-0.23 (-5.35%)

GLW Corning
$44.30 /

-0.38 (-0.85%)

GILD Gilead
$65.59 /

-0.67 (-1.01%)

FTV Fortive
$71.39 /

+0.25 (+0.35%)

FOLD Amicus
$9.37 /

-0.19 (-1.99%)

FLXN Flexion
$8.34 /

-0.37 (-4.25%)

DTIL Precision BioSciences
$8.92 /

-0.34 (-3.67%)

DOV Dover
$139.17 /

-0.27 (-0.19%)

DBTX Decibel Therapeutics
$11.06 /

-0.44 (-3.83%)

CYRX Cryoport
$51.23 /

-0.27 (-0.52%)

CABA Cabaletta Bio
$10.54 /

-1.02 (-8.82%)

BLUE Bluebird Bio
$30.06 /

-0.1 (-0.33%)

ATRA Atara Biotherapeutics
$14.22 /

+0.065 (+0.46%)

AGTC Applied Genetic
$4.45 /

-0.29 (-6.12%)

ADAP Adaptimmune
$4.96 /

-0.3 (-5.70%)

BLUE Bluebird Bio
$30.06 /

-0.1 (-0.33%)

03/29/21 BMO Capital
Bluebird Bio price target raised to $35 from $31 at BMO Capital
03/29/21 Mizuho
Bluebird Bio approval could improve sentiment on shares, says Mizuho
03/29/21 Piper Sandler
Bluebird Bio price target raised to $35 from $30 at Piper Sandler
03/17/21 Stifel
Stifel says Bluebird Bio CMO exit 'a bit concerning but not thesis changing'
GILD Gilead
$65.59 /

-0.67 (-1.01%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Bernstein
Gilead upgraded to Outperform from Market Perform at Bernstein
03/30/21 Redburn
Gilead upgraded to Buy from Neutral at Redburn
03/15/21 Mizuho
Merck's Gilead collaboration likely to broaden reach of islatravir, says Mizuho
TMO Thermo Fisher
$466.27 /

-2.75 (-0.59%)

03/29/21 UBS
Thermo Fisher price target lowered to $560 from $588 at UBS
03/18/21 KeyBanc
Thermo Fisher upgraded to Overweight at KeyBanc after Sartorius guidance
03/18/21 KeyBanc
Thermo Fisher upgraded to Overweight from Sector Weight at KeyBanc
03/02/21 Barclays
Thermo Fisher initiated with an Overweight at Barclays
SGTX Sigilon Therapeutics
$18.35 /

-0.64 (-3.37%)

12/29/20 Barclays
Sigilon Therapeutics initiated with an Overweight at Barclays
12/29/20 Morgan Stanley
Sigilon Therapeutics initiated with an Equal Weight at Morgan Stanley
12/29/20 Jefferies
Sigilon Therapeutics initiated with a Buy at Jefferies
ADAP Adaptimmune
$4.96 /

-0.3 (-5.70%)

08/12/20 Piper Sandler
TCR2 Therapeutics initiated with an Overweight at Piper Sandler
06/01/20 Mizuho
Adaptimmune price target raised to $9 from $3 at Mizuho
05/29/20 JonesTrading
JonesTrading upgrades Adaptimmune to Buy after data alleviates 'key concern'
05/29/20 JonesTrading
Adaptimmune upgraded to Buy from Hold at JonesTrading
AGTC Applied Genetic
$4.45 /

-0.29 (-6.12%)

03/01/21 Stifel
Applied Genetic initiated with a Buy at Stifel
02/02/21 H.C. Wainwright
Applied Genetic price target raised to $24 from $18 at H.C. Wainwright
02/01/21 Roth Capital
Applied Genetic price target raised to $35 from $30 at Roth Capital
11/17/20 Roth Capital
Applied Genetic price target raised to $30 from $26 at Roth Capital
ATRA Atara Biotherapeutics
$14.22 /

+0.065 (+0.46%)

03/25/21 Evercore ISI
Viracta Therapeutics initiated with an Outperform at Evercore ISI
03/02/21 Citi
Atara Biotherapeutics upgraded to Buy at Citi following 35% pullback
03/02/21 Citi
Atara Biotherapeutics upgraded to Buy from Neutral at Citi
01/04/21 Roth Capital
Roth keeps Buy rating on Atara Biotherapeutics after filing delay
CABA Cabaletta Bio
$10.54 /

-1.02 (-8.82%)

03/17/21 H.C. Wainwright
Cabaletta Bio price target raised to $22 from $20 at H.C. Wainwright
01/08/21 Chardan
Cabaletta Bio initiated with a Buy at Chardan
10/13/20 H.C. Wainwright
Cabaletta Bio initiated with a Buy at H.C. Wainwright
FLXN Flexion
$8.34 /

-0.37 (-4.25%)

04/06/21 RBC Capital
Flexion transferred with an Outperform at RBC Capital
08/20/20 Goldman Sachs
Flexion initiated with a Neutral at Goldman Sachs
07/30/20 Oppenheimer
Flexion initiated with an Outperform at Oppenheimer
07/29/20
Fly Intel: Top five analyst initiations
DTIL Precision BioSciences
$8.92 /

-0.34 (-3.67%)

04/06/21 Stifel
Stifel sees Precision BioSciences' CEO transition as 'disconcerting'
02/24/21
Fly Intel: Top five analyst initiations
02/24/21 JonesTrading
Precision BioSciences initiated with a Buy at JonesTrading
01/29/21 JPMorgan
Precision BioSciences price target raised to $14 from $10 at JPMorgan
DOV Dover
$139.17 /

-0.27 (-0.19%)

04/06/21 Barclays
Dover price target raised to $155 from $145 at Barclays
01/28/21 Baird
Dover price target raised to $147 from $140 at Baird
01/28/21 Baird
Dover results a solid beat with guidance above consensus, says Baird
01/05/21 Barclays
Dover price target raised to $141 from $138 at Barclays
GNPX Genprex
$4.07 /

-0.23 (-5.35%)

01/26/21 National Securities
Genprex initiated with a Buy at National Securities
04/22/20 Alliance Global Partners
Genprex initiated with a Buy at Alliance Global Partners
DBTX Decibel Therapeutics
$11.06 /

-0.44 (-3.83%)

03/09/21 Citi
Decibel Therapeutics initiated with a Buy at Citi
03/09/21 SVB Leerink
Decibel Therapeutics initiated with an Outperform at SVB Leerink
03/09/21 Barclays
Decibel Therapeutics initiated with an Overweight at Barclays
03/09/21 BMO Capital
Decibel Therapeutics initiated with an Outperform at BMO Capital
CYRX Cryoport
$51.23 /

-0.27 (-0.52%)

03/15/21
Fly Intel: Top five analyst initiations
03/15/21 UBS
Cryoport initiated with a Buy at UBS
03/02/21
Fly Intel: Top five analyst initiations
03/02/21 Needham
Cryoport assumed with a Buy at Needham
GLW Corning
$44.30 /

-0.38 (-0.85%)

04/07/21 Argus
Corning price target raised to $54 from $42 at Argus
01/28/21 Oppenheimer
Corning upgraded to Outperform from Perform at Oppenheimer
01/14/21 Barclays
Corning upgraded to Overweight with $44 target at Barclays
01/14/21 Barclays
Corning upgraded to Overweight from Equal Weight at Barclays
FTV Fortive
$71.39 /

+0.25 (+0.35%)

04/06/21 Barclays
Fortive price target raised to $73 from $72 at Barclays
02/17/21
Fly Intel: Top five analyst downgrades
02/17/21 Morgan Stanley
Fortive downgraded to Equal Weight at Morgan Stanley after re-rating
02/17/21 Morgan Stanley
Fortive downgraded to Equal Weight from Overweight at Morgan Stanley
KRYS Krystal Biotech
$73.72 /

-0.23 (-0.31%)

03/01/21 H.C. Wainwright
Krystal Biotech price target raised to $103 from $84 at H.C. Wainwright
03/01/21 William Blair
Krystal Biotech has 'catalyst-rich year ahead,' says William Blair
02/09/21 JonesTrading
Krystal Biotech initiated with a Buy at JonesTrading
01/15/21 Chardan
Krystal Biotech named a 'Top Pick for 2021' at Chardan
NVO Novo Nordisk
$67.86 /

-0.185 (-0.27%)

02/11/21 UBS
Novo Nordisk price target raised to DKK 425 from DKK 415 at UBS
02/04/21 Barclays
Novo Nordisk price target raised to DKK 495 from DKK 485 at Barclays
01/20/21 Citi
Citi opens 'Positive Catalyst Watch' on Novo Nordisk
01/20/21 Credit Suisse
Novo Nordisk downgraded to Neutral from Outperform at Credit Suisse
NVS Novartis
$86.30 /

-0.09 (-0.10%)

04/05/21 Morgan Stanley
Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley
03/23/21 Societe Generale
Novartis price target raised to CHF 107 from CHF 104 at Societe Generale
03/22/21 Bernstein
Novartis initiated with a Market Perform at Bernstein
03/10/21
Fly Intel: Top five analyst downgrades
ORTX Orchard Therapeutics
$6.87 /

-0.22 (-3.10%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
MRK Merck
$76.13 /

+0.34 (+0.45%)

04/07/21 Mizuho
Mizuho sees Alkermes, Merck collaboration as important next step for nemvaleukin
04/06/21 RBC Capital
Merck transferred with a Sector Perform at RBC Capital
04/01/21 Morgan Stanley
Merck cancer pipeline underappreciated and 'set to flow,' says Morgan Stanley
MEDP Medpace
$167.40 /

-7.13 (-4.09%)

02/17/21 Truist
Medpace price target raised to $180 from $135 at Truist
02/16/21 Credit Suisse
Medpace price target raised to $178 from $155 at Credit Suisse
10/02/20 Truist
Medpace upgraded to Buy from Hold at Truist
07/29/20 Truist
Medpace price target raised to $124 from $95 at SunTrust
IOVA Iovance Biotherapeutics
$31.02 /

-0.98 (-3.06%)

03/08/21 H.C. Wainwright
Iovance Biotherapeutics upgraded to Buy from Neutral at H.C. Wainwright
01/29/21 Baird
Iovance Biotherapeutics assumed at Outperform at Baird
01/14/21 Oppenheimer
Iovance Biotherapeutics price target raised to $57 from $43 at Oppenheimer
12/17/20 Barclays
Iovance Biotherapeutics price target raised to $55 from $43 at Barclays
FOLD Amicus
$9.37 /

-0.19 (-1.99%)

03/01/21 Stifel
Amicus initiated with a Hold at Stifel
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 JPMorgan
Amicus downgraded to Neutral on Pompe disease miss at JPMorgan
02/12/21 SVB Leerink
Amicus downgraded to Market Perform from Outperform at SVB Leerink
TMO Thermo Fisher
$466.27 /

-2.75 (-0.59%)

SGTX Sigilon Therapeutics
$18.35 /

-0.64 (-3.37%)

ORTX Orchard Therapeutics
$6.87 /

-0.22 (-3.10%)

NVS Novartis
$86.30 /

-0.09 (-0.10%)

NVO Novo Nordisk
$67.86 /

-0.185 (-0.27%)

MRK Merck
$76.13 /

+0.34 (+0.45%)

MEDP Medpace
$167.40 /

-7.13 (-4.09%)

KRYS Krystal Biotech
$73.72 /

-0.23 (-0.31%)

IOVA Iovance Biotherapeutics
$31.02 /

-0.98 (-3.06%)

GLW Corning
$44.30 /

-0.38 (-0.85%)

GILD Gilead
$65.59 /

-0.67 (-1.01%)

FTV Fortive
$71.39 /

+0.25 (+0.35%)

FOLD Amicus
$9.37 /

-0.19 (-1.99%)

FLXN Flexion
$8.34 /

-0.37 (-4.25%)

DTIL Precision BioSciences
$8.92 /

-0.34 (-3.67%)

DOV Dover
$139.17 /

-0.27 (-0.19%)

CYRX Cryoport
$51.23 /

-0.27 (-0.52%)

CABA Cabaletta Bio
$10.54 /

-1.02 (-8.82%)

BLUE Bluebird Bio
$30.06 /

-0.1 (-0.33%)

ATRA Atara Biotherapeutics
$14.22 /

+0.065 (+0.46%)

AGTC Applied Genetic
$4.45 /

-0.29 (-6.12%)

ADAP Adaptimmune
$4.96 /

-0.3 (-5.70%)

  • 12
    Feb
  • 03
    Feb
  • 28
    Jan
  • 21
    Jan
  • 09
    Dec
  • 04
    Dec
  • 02
    Jun
  • 29
    May
  • 27
    May
  • 21
    May
  • 19
    May
  • 19
    May
TMO Thermo Fisher
$466.27 /

-2.75 (-0.59%)

NVS Novartis
$86.30 /

-0.09 (-0.10%)

MRK Merck
$76.13 /

+0.34 (+0.45%)

GLW Corning
$44.30 /

-0.38 (-0.85%)

GILD Gilead
$65.59 /

-0.67 (-1.01%)

FTV Fortive
$71.39 /

+0.25 (+0.35%)

FOLD Amicus
$9.37 /

-0.19 (-1.99%)

CYRX Cryoport
$51.23 /

-0.27 (-0.52%)

BLUE Bluebird Bio
$30.06 /

-0.1 (-0.33%)

TMO Thermo Fisher
$466.27 /

-2.75 (-0.59%)

SGTX Sigilon Therapeutics
$18.35 /

-0.64 (-3.37%)

NVS Novartis
$86.30 /

-0.09 (-0.10%)

MRK Merck
$76.13 /

+0.34 (+0.45%)

GLW Corning
$44.30 /

-0.38 (-0.85%)

GILD Gilead
$65.59 /

-0.67 (-1.01%)

FOLD Amicus
$9.37 /

-0.19 (-1.99%)

DTIL Precision BioSciences
$8.92 /

-0.34 (-3.67%)

DOV Dover
$139.17 /

-0.27 (-0.19%)

DBTX Decibel Therapeutics
$11.06 /

-0.44 (-3.83%)

BLUE Bluebird Bio
$30.06 /

-0.1 (-0.33%)

ATRA Atara Biotherapeutics
$14.22 /

+0.065 (+0.46%)

AGTC Applied Genetic
$4.45 /

-0.29 (-6.12%)

NVO Novo Nordisk
$67.86 /

-0.185 (-0.27%)

MRK Merck
$76.13 /

+0.34 (+0.45%)

GLW Corning
$44.30 /

-0.38 (-0.85%)

GILD Gilead
$65.59 /

-0.67 (-1.01%)

FOLD Amicus
$9.37 /

-0.19 (-1.99%)

CABA Cabaletta Bio
$10.54 /

-1.02 (-8.82%)

BLUE Bluebird Bio
$30.06 /

-0.1 (-0.33%)

Conference/Events
Alliance for Regenerative Medicine to hold a virtual meeting » 04:55
04/07/21
04/07
04:55
04/07/21
04:55
BLUE

Bluebird Bio

$30.15 /

-0.95 (-3.05%)

, GILD

Gilead

$66.26 /

-0.09 (-0.14%)

, TMO

Thermo Fisher

$469.09 /

+3.53 (+0.76%)

, SGTX

Sigilon Therapeutics

$19.05 /

-0.965 (-4.82%)

, ADAP

Adaptimmune

$5.26 /

-0.35 (-6.24%)

, AGTC

Applied Genetic

$4.74 /

-0.26 (-5.20%)

, ATRA

Atara Biotherapeutics

$14.15 /

-0.53 (-3.61%)

, CABA

Cabaletta Bio

$11.21 /

-0.4 (-3.45%)

, FLXN

Flexion

$8.71 /

-0.11 (-1.25%)

, DTIL

Precision BioSciences

$9.23 /

-1.24 (-11.84%)

, DOV

Dover

$139.44 /

-0.74 (-0.53%)

, GNPX

Genprex

$4.29 /

+0.06 (+1.42%)

, DBTX

Decibel Therapeutics

$11.48 /

+0.09 (+0.79%)

, CYRX

Cryoport

$51.47 /

+1.1 (+2.18%)

, GLW

Corning

$44.68 /

-0.81 (-1.78%)

, FTV

Fortive

$71.18 /

-0.78 (-1.08%)

, KRYS

Krystal Biotech

$74.13 /

-4.6 (-5.84%)

, NVO

Novo Nordisk

$68.05 /

-0.235 (-0.34%)

, NVS

Novartis

$86.40 /

-0.89 (-1.02%)

, ORTX

Orchard Therapeutics

$7.09 /

-0.14 (-1.94%)

, MRK

Merck

$75.79 /

-1.21 (-1.57%)

, MEDP

Medpace

$171.71 /

+0.78 (+0.46%)

, IOVA

Iovance Biotherapeutics

$31.99 /

-0.16 (-0.50%)

, FOLD

Amicus

$9.56 /

-0.3848 (-3.87%)

Cell & Gene Virtual…

Cell & Gene Virtual Meeting on the Mediterranean will be held on April 6-9. Webcast Link

ShowHide Related Items >><<
TMO Thermo Fisher
$469.09 /

+3.53 (+0.76%)

SGTX Sigilon Therapeutics
$19.05 /

-0.965 (-4.82%)

ORTX Orchard Therapeutics
$7.09 /

-0.14 (-1.94%)

NVS Novartis
$86.40 /

-0.89 (-1.02%)

NVO Novo Nordisk
$68.05 /

-0.235 (-0.34%)

MRK Merck
$75.79 /

-1.21 (-1.57%)

KRYS Krystal Biotech
$74.13 /

-4.6 (-5.84%)

IOVA Iovance Biotherapeutics
$31.99 /

-0.16 (-0.50%)

GNPX Genprex
$4.29 /

+0.06 (+1.42%)

GLW Corning
$44.68 /

-0.81 (-1.78%)

GILD Gilead
$66.26 /

-0.09 (-0.14%)

FTV Fortive
$71.18 /

-0.78 (-1.08%)

FOLD Amicus
$9.56 /

-0.3848 (-3.87%)

FLXN Flexion
$8.71 /

-0.11 (-1.25%)

DTIL Precision BioSciences
$9.23 /

-1.24 (-11.84%)

DOV Dover
$139.44 /

-0.74 (-0.53%)

DBTX Decibel Therapeutics
$11.48 /

+0.09 (+0.79%)

CYRX Cryoport
$51.47 /

+1.1 (+2.18%)

CABA Cabaletta Bio
$11.21 /

-0.4 (-3.45%)

BLUE Bluebird Bio
$30.15 /

-0.95 (-3.05%)

ATRA Atara Biotherapeutics
$14.15 /

-0.53 (-3.61%)

AGTC Applied Genetic
$4.74 /

-0.26 (-5.20%)

ADAP Adaptimmune
$5.26 /

-0.35 (-6.24%)

BLUE Bluebird Bio
$30.15 /

-0.95 (-3.05%)

03/29/21 BMO Capital
Bluebird Bio price target raised to $35 from $31 at BMO Capital
03/29/21 Mizuho
Bluebird Bio approval could improve sentiment on shares, says Mizuho
03/29/21 Piper Sandler
Bluebird Bio price target raised to $35 from $30 at Piper Sandler
03/17/21 Stifel
Stifel says Bluebird Bio CMO exit 'a bit concerning but not thesis changing'
GILD Gilead
$66.26 /

-0.09 (-0.14%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Bernstein
Gilead upgraded to Outperform from Market Perform at Bernstein
03/30/21 Redburn
Gilead upgraded to Buy from Neutral at Redburn
03/15/21 Mizuho
Merck's Gilead collaboration likely to broaden reach of islatravir, says Mizuho
TMO Thermo Fisher
$469.09 /

+3.53 (+0.76%)

03/29/21 UBS
Thermo Fisher price target lowered to $560 from $588 at UBS
03/18/21 KeyBanc
Thermo Fisher upgraded to Overweight at KeyBanc after Sartorius guidance
03/18/21 KeyBanc
Thermo Fisher upgraded to Overweight from Sector Weight at KeyBanc
03/02/21 Barclays
Thermo Fisher initiated with an Overweight at Barclays
SGTX Sigilon Therapeutics
$19.05 /

-0.965 (-4.82%)

12/29/20 Barclays
Sigilon Therapeutics initiated with an Overweight at Barclays
12/29/20 Morgan Stanley
Sigilon Therapeutics initiated with an Equal Weight at Morgan Stanley
12/29/20 Jefferies
Sigilon Therapeutics initiated with a Buy at Jefferies
ADAP Adaptimmune
$5.26 /

-0.35 (-6.24%)

08/12/20 Piper Sandler
TCR2 Therapeutics initiated with an Overweight at Piper Sandler
06/01/20 Mizuho
Adaptimmune price target raised to $9 from $3 at Mizuho
05/29/20 JonesTrading
JonesTrading upgrades Adaptimmune to Buy after data alleviates 'key concern'
05/29/20 JonesTrading
Adaptimmune upgraded to Buy from Hold at JonesTrading
AGTC Applied Genetic
$4.74 /

-0.26 (-5.20%)

03/01/21 Stifel
Applied Genetic initiated with a Buy at Stifel
02/02/21 H.C. Wainwright
Applied Genetic price target raised to $24 from $18 at H.C. Wainwright
02/01/21 Roth Capital
Applied Genetic price target raised to $35 from $30 at Roth Capital
11/17/20 Roth Capital
Applied Genetic price target raised to $30 from $26 at Roth Capital
ATRA Atara Biotherapeutics
$14.15 /

-0.53 (-3.61%)

03/25/21 Evercore ISI
Viracta Therapeutics initiated with an Outperform at Evercore ISI
03/02/21 Citi
Atara Biotherapeutics upgraded to Buy at Citi following 35% pullback
03/02/21 Citi
Atara Biotherapeutics upgraded to Buy from Neutral at Citi
01/04/21 Roth Capital
Roth keeps Buy rating on Atara Biotherapeutics after filing delay
CABA Cabaletta Bio
$11.21 /

-0.4 (-3.45%)

03/17/21 H.C. Wainwright
Cabaletta Bio price target raised to $22 from $20 at H.C. Wainwright
01/08/21 Chardan
Cabaletta Bio initiated with a Buy at Chardan
10/13/20 H.C. Wainwright
Cabaletta Bio initiated with a Buy at H.C. Wainwright
FLXN Flexion
$8.71 /

-0.11 (-1.25%)

04/06/21 RBC Capital
Flexion transferred with an Outperform at RBC Capital
08/20/20 Goldman Sachs
Flexion initiated with a Neutral at Goldman Sachs
07/30/20 Oppenheimer
Flexion initiated with an Outperform at Oppenheimer
07/29/20
Fly Intel: Top five analyst initiations
DTIL Precision BioSciences
$9.23 /

-1.24 (-11.84%)

04/06/21 Stifel
Stifel sees Precision BioSciences' CEO transition as 'disconcerting'
02/24/21
Fly Intel: Top five analyst initiations
02/24/21 JonesTrading
Precision BioSciences initiated with a Buy at JonesTrading
01/29/21 JPMorgan
Precision BioSciences price target raised to $14 from $10 at JPMorgan
DOV Dover
$139.44 /

-0.74 (-0.53%)

04/06/21 Barclays
Dover price target raised to $155 from $145 at Barclays
01/28/21 Baird
Dover price target raised to $147 from $140 at Baird
01/28/21 Baird
Dover results a solid beat with guidance above consensus, says Baird
01/05/21 Barclays
Dover price target raised to $141 from $138 at Barclays
GNPX Genprex
$4.29 /

+0.06 (+1.42%)

01/26/21 National Securities
Genprex initiated with a Buy at National Securities
04/22/20 Alliance Global Partners
Genprex initiated with a Buy at Alliance Global Partners
DBTX Decibel Therapeutics
$11.48 /

+0.09 (+0.79%)

03/09/21 Citi
Decibel Therapeutics initiated with a Buy at Citi
03/09/21 SVB Leerink
Decibel Therapeutics initiated with an Outperform at SVB Leerink
03/09/21 Barclays
Decibel Therapeutics initiated with an Overweight at Barclays
03/09/21 BMO Capital
Decibel Therapeutics initiated with an Outperform at BMO Capital
CYRX Cryoport
$51.47 /

+1.1 (+2.18%)

03/15/21
Fly Intel: Top five analyst initiations
03/15/21 UBS
Cryoport initiated with a Buy at UBS
03/02/21
Fly Intel: Top five analyst initiations
03/02/21 Needham
Cryoport assumed with a Buy at Needham
GLW Corning
$44.68 /

-0.81 (-1.78%)

01/28/21 Oppenheimer
Corning upgraded to Outperform from Perform at Oppenheimer
01/14/21 Barclays
Corning upgraded to Overweight with $44 target at Barclays
01/14/21 Barclays
Corning upgraded to Overweight from Equal Weight at Barclays
01/06/21
Fly Intel: Top five analyst initiations
FTV Fortive
$71.18 /

-0.78 (-1.08%)

04/06/21 Barclays
Fortive price target raised to $73 from $72 at Barclays
02/17/21
Fly Intel: Top five analyst downgrades
02/17/21 Morgan Stanley
Fortive downgraded to Equal Weight at Morgan Stanley after re-rating
02/17/21 Morgan Stanley
Fortive downgraded to Equal Weight from Overweight at Morgan Stanley
KRYS Krystal Biotech
$74.13 /

-4.6 (-5.84%)

03/01/21 H.C. Wainwright
Krystal Biotech price target raised to $103 from $84 at H.C. Wainwright
03/01/21 William Blair
Krystal Biotech has 'catalyst-rich year ahead,' says William Blair
02/09/21 JonesTrading
Krystal Biotech initiated with a Buy at JonesTrading
01/15/21 Chardan
Krystal Biotech named a 'Top Pick for 2021' at Chardan
NVO Novo Nordisk
$68.05 /

-0.235 (-0.34%)

02/11/21 UBS
Novo Nordisk price target raised to DKK 425 from DKK 415 at UBS
02/04/21 Barclays
Novo Nordisk price target raised to DKK 495 from DKK 485 at Barclays
01/20/21 Citi
Citi opens 'Positive Catalyst Watch' on Novo Nordisk
01/20/21 Credit Suisse
Novo Nordisk downgraded to Neutral from Outperform at Credit Suisse
NVS Novartis
$86.40 /

-0.89 (-1.02%)

04/05/21 Morgan Stanley
Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley
03/23/21 Societe Generale
Novartis price target raised to CHF 107 from CHF 104 at Societe Generale
03/22/21 Bernstein
Novartis initiated with a Market Perform at Bernstein
03/10/21
Fly Intel: Top five analyst downgrades
ORTX Orchard Therapeutics
$7.09 /

-0.14 (-1.94%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
MRK Merck
$75.79 /

-1.21 (-1.57%)

04/06/21 RBC Capital
Merck transferred with a Sector Perform at RBC Capital
04/01/21 Morgan Stanley
Merck cancer pipeline underappreciated and 'set to flow,' says Morgan Stanley
03/15/21 Piper Sandler
Gilead pact with Merck can bring HIV sustainability, says Piper Sandler
MEDP Medpace
$171.71 /

+0.78 (+0.46%)

02/17/21 Truist
Medpace price target raised to $180 from $135 at Truist
02/16/21 Credit Suisse
Medpace price target raised to $178 from $155 at Credit Suisse
10/02/20 Truist
Medpace upgraded to Buy from Hold at Truist
07/29/20 Truist
Medpace price target raised to $124 from $95 at SunTrust
IOVA Iovance Biotherapeutics
$31.99 /

-0.16 (-0.50%)

03/08/21 H.C. Wainwright
Iovance Biotherapeutics upgraded to Buy from Neutral at H.C. Wainwright
01/29/21 Baird
Iovance Biotherapeutics assumed at Outperform at Baird
01/14/21 Oppenheimer
Iovance Biotherapeutics price target raised to $57 from $43 at Oppenheimer
12/17/20 Barclays
Iovance Biotherapeutics price target raised to $55 from $43 at Barclays
FOLD Amicus
$9.56 /

-0.3848 (-3.87%)

03/01/21 Stifel
Amicus initiated with a Hold at Stifel
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 JPMorgan
Amicus downgraded to Neutral on Pompe disease miss at JPMorgan
02/12/21 SVB Leerink
Amicus downgraded to Market Perform from Outperform at SVB Leerink
TMO Thermo Fisher
$469.09 /

+3.53 (+0.76%)

SGTX Sigilon Therapeutics
$19.05 /

-0.965 (-4.82%)

ORTX Orchard Therapeutics
$7.09 /

-0.14 (-1.94%)

NVS Novartis
$86.40 /

-0.89 (-1.02%)

NVO Novo Nordisk
$68.05 /

-0.235 (-0.34%)

MRK Merck
$75.79 /

-1.21 (-1.57%)

MEDP Medpace
$171.71 /

+0.78 (+0.46%)

KRYS Krystal Biotech
$74.13 /

-4.6 (-5.84%)

IOVA Iovance Biotherapeutics
$31.99 /

-0.16 (-0.50%)

GLW Corning
$44.68 /

-0.81 (-1.78%)

GILD Gilead
$66.26 /

-0.09 (-0.14%)

FTV Fortive
$71.18 /

-0.78 (-1.08%)

FOLD Amicus
$9.56 /

-0.3848 (-3.87%)

FLXN Flexion
$8.71 /

-0.11 (-1.25%)

DTIL Precision BioSciences
$9.23 /

-1.24 (-11.84%)

DOV Dover
$139.44 /

-0.74 (-0.53%)

CYRX Cryoport
$51.47 /

+1.1 (+2.18%)

CABA Cabaletta Bio
$11.21 /

-0.4 (-3.45%)

BLUE Bluebird Bio
$30.15 /

-0.95 (-3.05%)

ATRA Atara Biotherapeutics
$14.15 /

-0.53 (-3.61%)

AGTC Applied Genetic
$4.74 /

-0.26 (-5.20%)

ADAP Adaptimmune
$5.26 /

-0.35 (-6.24%)

  • 12
    Feb
  • 03
    Feb
  • 28
    Jan
  • 21
    Jan
  • 09
    Dec
  • 04
    Dec
  • 02
    Jun
  • 29
    May
  • 27
    May
  • 21
    May
  • 19
    May
  • 19
    May
TMO Thermo Fisher
$469.09 /

+3.53 (+0.76%)

NVS Novartis
$86.40 /

-0.89 (-1.02%)

MRK Merck
$75.79 /

-1.21 (-1.57%)

GLW Corning
$44.68 /

-0.81 (-1.78%)

GILD Gilead
$66.26 /

-0.09 (-0.14%)

FTV Fortive
$71.18 /

-0.78 (-1.08%)

FOLD Amicus
$9.56 /

-0.3848 (-3.87%)

CYRX Cryoport
$51.47 /

+1.1 (+2.18%)

BLUE Bluebird Bio
$30.15 /

-0.95 (-3.05%)

TMO Thermo Fisher
$469.09 /

+3.53 (+0.76%)

SGTX Sigilon Therapeutics
$19.05 /

-0.965 (-4.82%)

NVS Novartis
$86.40 /

-0.89 (-1.02%)

MRK Merck
$75.79 /

-1.21 (-1.57%)

GLW Corning
$44.68 /

-0.81 (-1.78%)

GILD Gilead
$66.26 /

-0.09 (-0.14%)

FOLD Amicus
$9.56 /

-0.3848 (-3.87%)

DTIL Precision BioSciences
$9.23 /

-1.24 (-11.84%)

DOV Dover
$139.44 /

-0.74 (-0.53%)

DBTX Decibel Therapeutics
$11.48 /

+0.09 (+0.79%)

BLUE Bluebird Bio
$30.15 /

-0.95 (-3.05%)

ATRA Atara Biotherapeutics
$14.15 /

-0.53 (-3.61%)

AGTC Applied Genetic
$4.74 /

-0.26 (-5.20%)

NVO Novo Nordisk
$68.05 /

-0.235 (-0.34%)

MRK Merck
$75.79 /

-1.21 (-1.57%)

IOVA Iovance Biotherapeutics
$31.99 /

-0.16 (-0.50%)

GLW Corning
$44.68 /

-0.81 (-1.78%)

GILD Gilead
$66.26 /

-0.09 (-0.14%)

FOLD Amicus
$9.56 /

-0.3848 (-3.87%)

CABA Cabaletta Bio
$11.21 /

-0.4 (-3.45%)

BLUE Bluebird Bio
$30.15 /

-0.95 (-3.05%)

Conference/Events
Alliance for Regenerative Medicine to hold a virtual meeting » 09:55
04/06/21
04/06
09:55
04/06/21
09:55
BLUE

Bluebird Bio

$30.45 /

-0.65 (-2.09%)

, GILD

Gilead

$66.10 /

-0.25 (-0.38%)

, TMO

Thermo Fisher

$465.69 /

+0.13 (+0.03%)

, SGTX

Sigilon Therapeutics

$20.04 /

+0.02 (+0.10%)

, ADAP

Adaptimmune

$5.58 /

-0.03 (-0.53%)

, AGTC

Applied Genetic

$4.95 /

-0.05 (-1.00%)

, ATRA

Atara Biotherapeutics

$14.68 /

+ (+0.00%)

, CABA

Cabaletta Bio

$11.61 /

+ (+0.00%)

, FLXN

Flexion

$8.65 /

-0.17 (-1.93%)

, DTIL

Precision BioSciences

$10.30 /

-0.17 (-1.62%)

, DOV

Dover

$140.45 /

+0.27 (+0.19%)

, GNPX

Genprex

$4.14 /

-0.09 (-2.13%)

, DBTX

Decibel Therapeutics

$11.36 /

-0.03 (-0.26%)

, CYRX

Cryoport

$50.71 /

+0.34 (+0.68%)

, GLW

Corning

$45.30 /

-0.19 (-0.42%)

, FTV

Fortive

$72.04 /

+0.08 (+0.11%)

, KRYS

Krystal Biotech

$78.76 /

+0.03 (+0.04%)

, NVO

Novo Nordisk

$68.09 /

-0.19 (-0.28%)

, NVS

Novartis

$87.06 /

-0.23 (-0.26%)

, ORTX

Orchard Therapeutics

$7.19 /

-0.04 (-0.55%)

, MRK

Merck

$76.44 /

-0.56 (-0.73%)

, MEDP

Medpace

$173.03 /

+2.1 (+1.23%)

, IOVA

Iovance Biotherapeutics

$31.80 /

-0.35 (-1.09%)

, FOLD

Amicus

$9.89 /

-0.055 (-0.55%)

Cell & Gene Virtual…

Cell & Gene Virtual Meeting on the Mediterranean will be held on April 6-9. Webcast Link

ShowHide Related Items >><<
TMO Thermo Fisher
$465.69 /

+0.13 (+0.03%)

SGTX Sigilon Therapeutics
$20.04 /

+0.02 (+0.10%)

ORTX Orchard Therapeutics
$7.19 /

-0.04 (-0.55%)

NVS Novartis
$87.06 /

-0.23 (-0.26%)

NVO Novo Nordisk
$68.09 /

-0.19 (-0.28%)

MRK Merck
$76.44 /

-0.56 (-0.73%)

KRYS Krystal Biotech
$78.76 /

+0.03 (+0.04%)

IOVA Iovance Biotherapeutics
$31.80 /

-0.35 (-1.09%)

GNPX Genprex
$4.14 /

-0.09 (-2.13%)

GLW Corning
$45.30 /

-0.19 (-0.42%)

GILD Gilead
$66.10 /

-0.25 (-0.38%)

FTV Fortive
$72.04 /

+0.08 (+0.11%)

FOLD Amicus
$9.89 /

-0.055 (-0.55%)

FLXN Flexion
$8.65 /

-0.17 (-1.93%)

DTIL Precision BioSciences
$10.30 /

-0.17 (-1.62%)

DOV Dover
$140.45 /

+0.27 (+0.19%)

DBTX Decibel Therapeutics
$11.36 /

-0.03 (-0.26%)

CYRX Cryoport
$50.71 /

+0.34 (+0.68%)

CABA Cabaletta Bio
$11.61 /

+ (+0.00%)

BLUE Bluebird Bio
$30.45 /

-0.65 (-2.09%)

ATRA Atara Biotherapeutics
$14.68 /

+ (+0.00%)

AGTC Applied Genetic
$4.95 /

-0.05 (-1.00%)

ADAP Adaptimmune
$5.58 /

-0.03 (-0.53%)

BLUE Bluebird Bio
$30.45 /

-0.65 (-2.09%)

03/29/21 BMO Capital
Bluebird Bio price target raised to $35 from $31 at BMO Capital
03/29/21 Mizuho
Bluebird Bio approval could improve sentiment on shares, says Mizuho
03/29/21 Piper Sandler
Bluebird Bio price target raised to $35 from $30 at Piper Sandler
03/17/21 Stifel
Stifel says Bluebird Bio CMO exit 'a bit concerning but not thesis changing'
GILD Gilead
$66.10 /

-0.25 (-0.38%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Bernstein
Gilead upgraded to Outperform from Market Perform at Bernstein
03/30/21 Redburn
Gilead upgraded to Buy from Neutral at Redburn
03/15/21 Mizuho
Merck's Gilead collaboration likely to broaden reach of islatravir, says Mizuho
TMO Thermo Fisher
$465.69 /

+0.13 (+0.03%)

03/29/21 UBS
Thermo Fisher price target lowered to $560 from $588 at UBS
03/18/21 KeyBanc
Thermo Fisher upgraded to Overweight at KeyBanc after Sartorius guidance
03/18/21 KeyBanc
Thermo Fisher upgraded to Overweight from Sector Weight at KeyBanc
03/02/21 Barclays
Thermo Fisher initiated with an Overweight at Barclays
SGTX Sigilon Therapeutics
$20.04 /

+0.02 (+0.10%)

12/29/20 Barclays
Sigilon Therapeutics initiated with an Overweight at Barclays
12/29/20 Morgan Stanley
Sigilon Therapeutics initiated with an Equal Weight at Morgan Stanley
12/29/20 Jefferies
Sigilon Therapeutics initiated with a Buy at Jefferies
ADAP Adaptimmune
$5.58 /

-0.03 (-0.53%)

08/12/20 Piper Sandler
TCR2 Therapeutics initiated with an Overweight at Piper Sandler
06/01/20 Mizuho
Adaptimmune price target raised to $9 from $3 at Mizuho
05/29/20 JonesTrading
JonesTrading upgrades Adaptimmune to Buy after data alleviates 'key concern'
05/29/20 JonesTrading
Adaptimmune upgraded to Buy from Hold at JonesTrading
AGTC Applied Genetic
$4.95 /

-0.05 (-1.00%)

03/01/21 Stifel
Applied Genetic initiated with a Buy at Stifel
02/02/21 H.C. Wainwright
Applied Genetic price target raised to $24 from $18 at H.C. Wainwright
02/01/21 Roth Capital
Applied Genetic price target raised to $35 from $30 at Roth Capital
11/17/20 Roth Capital
Applied Genetic price target raised to $30 from $26 at Roth Capital
ATRA Atara Biotherapeutics
$14.68 /

+ (+0.00%)

03/25/21 Evercore ISI
Viracta Therapeutics initiated with an Outperform at Evercore ISI
03/02/21 Citi
Atara Biotherapeutics upgraded to Buy at Citi following 35% pullback
03/02/21 Citi
Atara Biotherapeutics upgraded to Buy from Neutral at Citi
01/04/21 Roth Capital
Roth keeps Buy rating on Atara Biotherapeutics after filing delay
CABA Cabaletta Bio
$11.61 /

+ (+0.00%)

03/17/21 H.C. Wainwright
Cabaletta Bio price target raised to $22 from $20 at H.C. Wainwright
01/08/21 Chardan
Cabaletta Bio initiated with a Buy at Chardan
10/13/20 H.C. Wainwright
Cabaletta Bio initiated with a Buy at H.C. Wainwright
FLXN Flexion
$8.65 /

-0.17 (-1.93%)

08/20/20 Goldman Sachs
Flexion initiated with a Neutral at Goldman Sachs
07/30/20 Oppenheimer
Flexion initiated with an Outperform at Oppenheimer
07/29/20
Fly Intel: Top five analyst initiations
07/29/20 Credit Suisse
Flexion initiated with an Outperform at Credit Suisse
DTIL Precision BioSciences
$10.30 /

-0.17 (-1.62%)

02/24/21
Fly Intel: Top five analyst initiations
02/24/21 JonesTrading
Precision BioSciences initiated with a Buy at JonesTrading
01/29/21 JPMorgan
Precision BioSciences price target raised to $14 from $10 at JPMorgan
12/15/20 H.C. Wainwright
Precision BioSciences transferred with Buy rating at H.C. Wainwright
DOV Dover
$140.45 /

+0.27 (+0.19%)

04/06/21 Barclays
Dover price target raised to $155 from $145 at Barclays
01/28/21 Baird
Dover price target raised to $147 from $140 at Baird
01/28/21 Baird
Dover results a solid beat with guidance above consensus, says Baird
01/05/21 Barclays
Dover price target raised to $141 from $138 at Barclays
GNPX Genprex
$4.14 /

-0.09 (-2.13%)

01/26/21 National Securities
Genprex initiated with a Buy at National Securities
04/22/20 Alliance Global Partners
Genprex initiated with a Buy at Alliance Global Partners
DBTX Decibel Therapeutics
$11.36 /

-0.03 (-0.26%)

03/09/21 Citi
Decibel Therapeutics initiated with a Buy at Citi
03/09/21 SVB Leerink
Decibel Therapeutics initiated with an Outperform at SVB Leerink
03/09/21 Barclays
Decibel Therapeutics initiated with an Overweight at Barclays
03/09/21 BMO Capital
Decibel Therapeutics initiated with an Outperform at BMO Capital
CYRX Cryoport
$50.71 /

+0.34 (+0.68%)

03/15/21
Fly Intel: Top five analyst initiations
03/15/21 UBS
Cryoport initiated with a Buy at UBS
03/02/21
Fly Intel: Top five analyst initiations
03/02/21 Needham
Cryoport assumed with a Buy at Needham
GLW Corning
$45.30 /

-0.19 (-0.42%)

01/28/21 Oppenheimer
Corning upgraded to Outperform from Perform at Oppenheimer
01/14/21 Barclays
Corning upgraded to Overweight with $44 target at Barclays
01/14/21 Barclays
Corning upgraded to Overweight from Equal Weight at Barclays
01/06/21
Fly Intel: Top five analyst initiations
FTV Fortive
$72.04 /

+0.08 (+0.11%)

04/06/21 Barclays
Fortive price target raised to $73 from $72 at Barclays
02/17/21
Fly Intel: Top five analyst downgrades
02/17/21 Morgan Stanley
Fortive downgraded to Equal Weight at Morgan Stanley after re-rating
02/17/21 Morgan Stanley
Fortive downgraded to Equal Weight from Overweight at Morgan Stanley
KRYS Krystal Biotech
$78.76 /

+0.03 (+0.04%)

03/01/21 H.C. Wainwright
Krystal Biotech price target raised to $103 from $84 at H.C. Wainwright
03/01/21 William Blair
Krystal Biotech has 'catalyst-rich year ahead,' says William Blair
02/09/21 JonesTrading
Krystal Biotech initiated with a Buy at JonesTrading
01/15/21 Chardan
Krystal Biotech named a 'Top Pick for 2021' at Chardan
NVO Novo Nordisk
$68.09 /

-0.19 (-0.28%)

02/11/21 UBS
Novo Nordisk price target raised to DKK 425 from DKK 415 at UBS
02/04/21 Barclays
Novo Nordisk price target raised to DKK 495 from DKK 485 at Barclays
01/20/21 Citi
Citi opens 'Positive Catalyst Watch' on Novo Nordisk
01/20/21 Credit Suisse
Novo Nordisk downgraded to Neutral from Outperform at Credit Suisse
NVS Novartis
$87.06 /

-0.23 (-0.26%)

04/05/21 Morgan Stanley
Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley
03/23/21 Societe Generale
Novartis price target raised to CHF 107 from CHF 104 at Societe Generale
03/22/21 Bernstein
Novartis initiated with a Market Perform at Bernstein
03/10/21
Fly Intel: Top five analyst downgrades
ORTX Orchard Therapeutics
$7.19 /

-0.04 (-0.55%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
MRK Merck
$76.44 /

-0.56 (-0.73%)

04/01/21 Morgan Stanley
Merck cancer pipeline underappreciated and 'set to flow,' says Morgan Stanley
03/15/21 Piper Sandler
Gilead pact with Merck can bring HIV sustainability, says Piper Sandler
02/25/21 SVB Leerink
Pandion Therapeutics downgraded to Market Perform from Outperform at SVB Leerink
MEDP Medpace
$173.03 /

+2.1 (+1.23%)

02/17/21 Truist
Medpace price target raised to $180 from $135 at Truist
02/16/21 Credit Suisse
Medpace price target raised to $178 from $155 at Credit Suisse
10/02/20 Truist
Medpace upgraded to Buy from Hold at Truist
07/29/20 Truist
Medpace price target raised to $124 from $95 at SunTrust
IOVA Iovance Biotherapeutics
$31.80 /

-0.35 (-1.09%)

03/08/21 H.C. Wainwright
Iovance Biotherapeutics upgraded to Buy from Neutral at H.C. Wainwright
01/29/21 Baird
Iovance Biotherapeutics assumed at Outperform at Baird
01/14/21 Oppenheimer
Iovance Biotherapeutics price target raised to $57 from $43 at Oppenheimer
12/17/20 Barclays
Iovance Biotherapeutics price target raised to $55 from $43 at Barclays
FOLD Amicus
$9.89 /

-0.055 (-0.55%)

03/01/21 Stifel
Amicus initiated with a Hold at Stifel
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 JPMorgan
Amicus downgraded to Neutral on Pompe disease miss at JPMorgan
02/12/21 SVB Leerink
Amicus downgraded to Market Perform from Outperform at SVB Leerink
TMO Thermo Fisher
$465.69 /

+0.13 (+0.03%)

SGTX Sigilon Therapeutics
$20.04 /

+0.02 (+0.10%)

ORTX Orchard Therapeutics
$7.19 /

-0.04 (-0.55%)

NVS Novartis
$87.06 /

-0.23 (-0.26%)

NVO Novo Nordisk
$68.09 /

-0.19 (-0.28%)

MRK Merck
$76.44 /

-0.56 (-0.73%)

MEDP Medpace
$173.03 /

+2.1 (+1.23%)

KRYS Krystal Biotech
$78.76 /

+0.03 (+0.04%)

IOVA Iovance Biotherapeutics
$31.80 /

-0.35 (-1.09%)

GLW Corning
$45.30 /

-0.19 (-0.42%)

GILD Gilead
$66.10 /

-0.25 (-0.38%)

FTV Fortive
$72.04 /

+0.08 (+0.11%)

FOLD Amicus
$9.89 /

-0.055 (-0.55%)

FLXN Flexion
$8.65 /

-0.17 (-1.93%)

DTIL Precision BioSciences
$10.30 /

-0.17 (-1.62%)

DOV Dover
$140.45 /

+0.27 (+0.19%)

CYRX Cryoport
$50.71 /

+0.34 (+0.68%)

CABA Cabaletta Bio
$11.61 /

+ (+0.00%)

BLUE Bluebird Bio
$30.45 /

-0.65 (-2.09%)

ATRA Atara Biotherapeutics
$14.68 /

+ (+0.00%)

AGTC Applied Genetic
$4.95 /

-0.05 (-1.00%)

ADAP Adaptimmune
$5.58 /

-0.03 (-0.53%)

  • 12
    Feb
  • 03
    Feb
  • 28
    Jan
  • 21
    Jan
  • 09
    Dec
  • 04
    Dec
  • 02
    Jun
  • 29
    May
  • 27
    May
  • 21
    May
  • 19
    May
  • 19
    May
TMO Thermo Fisher
$465.69 /

+0.13 (+0.03%)

NVS Novartis
$87.06 /

-0.23 (-0.26%)

MRK Merck
$76.44 /

-0.56 (-0.73%)

GLW Corning
$45.30 /

-0.19 (-0.42%)

GILD Gilead
$66.10 /

-0.25 (-0.38%)

FTV Fortive
$72.04 /

+0.08 (+0.11%)

FOLD Amicus
$9.89 /

-0.055 (-0.55%)

CYRX Cryoport
$50.71 /

+0.34 (+0.68%)

BLUE Bluebird Bio
$30.45 /

-0.65 (-2.09%)

TMO Thermo Fisher
$465.69 /

+0.13 (+0.03%)

SGTX Sigilon Therapeutics
$20.04 /

+0.02 (+0.10%)

NVS Novartis
$87.06 /

-0.23 (-0.26%)

MRK Merck
$76.44 /

-0.56 (-0.73%)

IOVA Iovance Biotherapeutics
$31.80 /

-0.35 (-1.09%)

GLW Corning
$45.30 /

-0.19 (-0.42%)

GILD Gilead
$66.10 /

-0.25 (-0.38%)

FOLD Amicus
$9.89 /

-0.055 (-0.55%)

DTIL Precision BioSciences
$10.30 /

-0.17 (-1.62%)

DOV Dover
$140.45 /

+0.27 (+0.19%)

DBTX Decibel Therapeutics
$11.36 /

-0.03 (-0.26%)

BLUE Bluebird Bio
$30.45 /

-0.65 (-2.09%)

ATRA Atara Biotherapeutics
$14.68 /

+ (+0.00%)

AGTC Applied Genetic
$4.95 /

-0.05 (-1.00%)

NVO Novo Nordisk
$68.09 /

-0.19 (-0.28%)

MRK Merck
$76.44 /

-0.56 (-0.73%)

IOVA Iovance Biotherapeutics
$31.80 /

-0.35 (-1.09%)

GLW Corning
$45.30 /

-0.19 (-0.42%)

GILD Gilead
$66.10 /

-0.25 (-0.38%)

FOLD Amicus
$9.89 /

-0.055 (-0.55%)

CABA Cabaletta Bio
$11.61 /

+ (+0.00%)

BLUE Bluebird Bio
$30.45 /

-0.65 (-2.09%)

Hot Stocks
Cryoport acquires Critical Transport Solutions Australia for $5M » 08:33
04/06/21
04/06
08:33
04/06/21
08:33
CYRX

Cryoport

$50.31 /

-2.2 (-4.19%)

Cryoport announced it has…

Cryoport announced it has acquired Critical Transport Solutions Australia, or CTSA, a market leader in providing premium healthcare logistics management services, specializing in time- and temperature-critical solutions for the medical and pharmaceutical industries based in Australia, for approximately $5M. CTSA will be a part of Cryoport's CRYOPDP business unit and will continue to be run by the current management team. Acquiring CTSA's distribution capabilities in Australia is expected to improve Cryoport's position to gain market share in APAC as the number of clinical trials taking place in the region continues to increase. The CTSA acquisition follows the opening of Cryoport Systems and CRYOPDP's first jointly operated global logistics center in Osaka, Japan, in the Q4 of FY20 and forms part of the Company's ongoing expansion strategy in APAC.

ShowHide Related Items >><<
CYRX Cryoport
$50.31 /

-2.2 (-4.19%)

CYRX Cryoport
$50.31 /

-2.2 (-4.19%)

03/15/21
Fly Intel: Top five analyst initiations
03/15/21 UBS
Cryoport initiated with a Buy at UBS
03/02/21
Fly Intel: Top five analyst initiations
03/02/21 Needham
Cryoport assumed with a Buy at Needham
CYRX Cryoport
$50.31 /

-2.2 (-4.19%)

  • 21
    Jan
CYRX Cryoport
$50.31 /

-2.2 (-4.19%)

Initiation
Fly Intel: Top five analyst initiations » 09:56
03/15/21
03/15
09:56
03/15/21
09:56
U

Unity Software

$106.00 /

+0.42 (+0.40%)

, CYRX

Cryoport

$60.21 /

+2.84 (+4.95%)

, OSH

Oak Street Health

$56.06 /

-0.48 (-0.85%)

, GLPI

Gaming and Leisure Properties

$43.89 /

+0.95 (+2.21%)

, TXG

10x Genomics

$165.00 /

+4.57 (+2.85%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Unity Software (U) initiated with a Buy at Goldman Sachs. 2. Cryoport (CYRX) initiated with a Buy at UBS. 3. Oak Street Health (OSH) initiated with an Outperform at Evercore ISI. 4. Gaming and Leisure Properties (GLPI) initiated with an Overweight at KeyBanc. 5. 10x Genomics (TXG) initiated with an Outperform at William Blair. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
U Unity Software
$106.00 /

+0.42 (+0.40%)

TXG 10x Genomics
$165.00 /

+4.57 (+2.85%)

OSH Oak Street Health
$56.06 /

-0.48 (-0.85%)

GLPI Gaming and Leisure Properties
$43.89 /

+0.95 (+2.21%)

CYRX Cryoport
$60.21 /

+2.84 (+4.95%)

U Unity Software
$106.00 /

+0.42 (+0.40%)

03/15/21 Goldman Sachs
Unity Software initiated with a Buy at Goldman Sachs
02/01/21 Wedbush
Unity Software price target raised to $175 from $150 at Wedbush
01/21/21 BofA
Unity Software downgraded to Underperform from Neutral at BofA
01/21/21 BofA
Unity Software downgraded to Underperform from Neutral at BofA
CYRX Cryoport
$60.21 /

+2.84 (+4.95%)

03/15/21 UBS
Cryoport initiated with a Buy at UBS
03/02/21
Fly Intel: Top five analyst initiations
03/02/21 Needham
Cryoport assumed with a Buy at Needham
02/10/21 B. Riley
Cryoport price target raised to $81 from $69 at B. Riley Securities
OSH Oak Street Health
$56.06 /

-0.48 (-0.85%)

03/15/21 Evercore ISI
Oak Street Health initiated with an Outperform at Evercore ISI
03/10/21 Piper Sandler
Oak Street Health accelerating revenue growth 'not baked in,' says Piper Sandler
02/24/21 Canaccord
Canaccord starts Oak Street Health at Buy with $67 price target
02/24/21 Canaccord
Oak Street Health initiated with a Buy at Canaccord
GLPI Gaming and Leisure Properties
$43.89 /

+0.95 (+2.21%)

03/15/21 KeyBanc
Gaming and Leisure Properties initiated with an Overweight at KeyBanc
02/22/21 Deutsche Bank
Gaming and Leisure Properties price target raised to $51 from $48 at Deutsche Bank
12/10/20 Ladenburg
Gaming and Leisure price target raised to $47.50 from $31.50 at Ladenburg
12/09/20 Deutsche Bank
Gaming and Leisure Properties price target raised to $48 from $42 at Deutsche Bank
TXG 10x Genomics
$165.00 /

+4.57 (+2.85%)

03/15/21 William Blair
10x Genomics initiated with an Outperform at William Blair
02/18/21 Cowen
10x Genomics price target raised to $200 from $155 at Cowen
02/18/21 JPMorgan
10x Genomics price target raised to $195 from $160 at JPMorgan
02/18/21 Citi
10x Genomics price target raised to $240 from $195 at Citi
U Unity Software
$106.00 /

+0.42 (+0.40%)

TXG 10x Genomics
$165.00 /

+4.57 (+2.85%)

OSH Oak Street Health
$56.06 /

-0.48 (-0.85%)

GLPI Gaming and Leisure Properties
$43.89 /

+0.95 (+2.21%)

CYRX Cryoport
$60.21 /

+2.84 (+4.95%)

  • 11
    Feb
  • 08
    Feb
  • 21
    Jan
  • 03
    Dec
  • 30
    Oct
  • 18
    Sep
  • 11
    Sep
  • 06
    Aug
U Unity Software
$106.00 /

+0.42 (+0.40%)

CYRX Cryoport
$60.21 /

+2.84 (+4.95%)

U Unity Software
$106.00 /

+0.42 (+0.40%)

TXG 10x Genomics
$165.00 /

+4.57 (+2.85%)

OSH Oak Street Health
$56.06 /

-0.48 (-0.85%)

U Unity Software
$106.00 /

+0.42 (+0.40%)

OSH Oak Street Health
$56.06 /

-0.48 (-0.85%)

Initiation
Cryoport initiated with a Buy at UBS » 06:14
03/15/21
03/15
06:14
03/15/21
06:14
CYRX

Cryoport

$57.54 /

+0.2 (+0.35%)

UBS analyst John Sourbeer…

UBS analyst John Sourbeer initiated coverage of Cryoport with a Buy rating and $84 price target. The analyst is positive on the company's leading position in temperature controlled logistics with a focus on high growth cell and gene therapy, or C&GTs, where he estimates a 30%-40% annual revenue growth. Sourbeer adds that based on his differentiated industry checks along with his view of the large pipeline of C&GTs, his revenue estimates for Cryoport's FY22 and FY23 are 14% and 27% above consensus respectively.

ShowHide Related Items >><<
CYRX Cryoport
$57.54 /

+0.2 (+0.35%)

CYRX Cryoport
$57.54 /

+0.2 (+0.35%)

03/02/21
Fly Intel: Top five analyst initiations
03/02/21 Needham
Cryoport assumed with a Buy at Needham
02/10/21 B. Riley
Cryoport price target raised to $81 from $69 at B. Riley Securities
01/19/21 KeyBanc
Cryoport price target raised to $75 from $54 at KeyBanc
CYRX Cryoport
$57.54 /

+0.2 (+0.35%)

  • 21
    Jan
CYRX Cryoport
$57.54 /

+0.2 (+0.35%)

Initiation
Fly Intel: Top five analyst initiations » 09:56
03/02/21
03/02
09:56
03/02/21
09:56
RCEL

Avita Medical

$22.70 /

+1.225 (+5.70%)

, MP

MP Materials

$48.73 /

+2.475 (+5.35%)

, BOLT

Bolt Biotherapeutics

$33.35 /

+3.22 (+10.69%)

, ANGN

Angion Biomedica

$20.00 /

+0.48 (+2.46%)

, CYRX

Cryoport

$60.85 /

-1.66 (-2.66%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Avita Medical (RCEL) initiated with an Overweight at Piper Sandler. 2. MP Materials (MP) initiated with an Overweight at Morgan Stanley. 3. Bolt Biotherapeutics (BOLT) initiated with an Outperform at SVB Leerink, a Buy at Stifel and an Overweight at Morgan Stanley. 4. Angion Biomedica (ANGN) initiated with an Outperform at Cowen and Oppenheimer, initiated with a Buy at Stifel. 5. Cryoport (CYRX) assumed with a Buy at Needham. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
RCEL Avita Medical
$22.70 /

+1.225 (+5.70%)

MP MP Materials
$48.73 /

+2.475 (+5.35%)

CYRX Cryoport
$60.85 /

-1.66 (-2.66%)

RCEL Avita Medical
$22.70 /

+1.225 (+5.70%)

03/02/21 Piper Sandler
Avita Medical initiated with an Overweight at Piper Sandler
08/27/20
Fly Intel: Top five analyst initiations
08/27/20 BofA
Avita Medical assumed with a Buy at BofA
07/09/20 BTIG
Avita Medical price target raised to $41 from $8 at BTIG
MP MP Materials
$48.73 /

+2.475 (+5.35%)

03/02/21 Morgan Stanley
Morgan Stanley starts MP Materials at Overweight on accelerating adoption of EVs
03/01/21 Morgan Stanley
MP Materials initiated with an Overweight at Morgan Stanley
12/03/20
Fly Intel: Top five analyst initiations
12/03/20 Northland
MP Materials initiated with an Outperform at Northland
BOLT Bolt Biotherapeutics
$33.35 /

+3.22 (+10.69%)

03/02/21 SVB Leerink
Bolt Biotherapeutics initiated with an Outperform at SVB Leerink
03/02/21 Morgan Stanley
Bolt Biotherapeutics initiated with an Overweight at Morgan Stanley
03/02/21 Stifel
Bolt Biotherapeutics initiated with a Buy at Stifel
03/02/21 SVB Leerink
Bolt Biotherapeutics initiated with an Outperform at SVB Leerink
ANGN Angion Biomedica
$20.00 /

+0.48 (+2.46%)

03/02/21 Cowen
Angion Biomedica initiated with an Outperform at Cowen
03/02/21 Oppenheimer
Angion Biomedica initiated with an Outperform at Oppenheimer
03/02/21 Stifel
Angion Biomedica initiated with a Buy at Stifel
03/02/21 Cowen
Angion Biomedica initiated with an Outperform at Cowen
CYRX Cryoport
$60.85 /

-1.66 (-2.66%)

03/02/21 Needham
Cryoport assumed with a Buy at Needham
02/10/21 B. Riley
Cryoport price target raised to $81 from $69 at B. Riley Securities
01/19/21 KeyBanc
Cryoport price target raised to $75 from $54 at KeyBanc
01/14/21 Roth Capital
Cryoport price target raised to $72 from $60 at Roth Capital
CYRX Cryoport
$60.85 /

-1.66 (-2.66%)

  • 25
    Feb
  • 05
    Feb
  • 05
    Feb
  • 21
    Jan
CYRX Cryoport
$60.85 /

-1.66 (-2.66%)

BOLT Bolt Biotherapeutics
$33.35 /

+3.22 (+10.69%)

MP MP Materials
$48.73 /

+2.475 (+5.35%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.